
### [NCIT:C4247](http://purl.obolibrary.org/obo/NCIT_C4247)
**Label:** Undifferentiated Pleomorphic Sarcoma

**Subclasses:** [NCIT:C8380](http://purl.obolibrary.org/obo/NCIT_C8380) (Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells), [NCIT:C5576](http://purl.obolibrary.org/obo/NCIT_C5576) (Cutaneous Undifferentiated Pleomorphic Sarcoma), [NCIT:C129566](http://purl.obolibrary.org/obo/NCIT_C129566) (Central Nervous System Undifferentiated Pleomorphic Sarcoma), [NCIT:C114541](http://purl.obolibrary.org/obo/NCIT_C114541) (Adult Undifferentiated Pleomorphic Sarcoma), [NCIT:C8795](http://purl.obolibrary.org/obo/NCIT_C8795) (Recurrent Undifferentiated Pleomorphic Sarcoma), [NCIT:C45755](http://purl.obolibrary.org/obo/NCIT_C45755) (Cardiac Undifferentiated Pleomorphic Sarcoma), [NCIT:C4926](http://purl.obolibrary.org/obo/NCIT_C4926) (Metastatic Undifferentiated Pleomorphic Sarcoma), [NCIT:C114749](http://purl.obolibrary.org/obo/NCIT_C114749) (Childhood Undifferentiated Pleomorphic Sarcoma), 

**Class expressions from DL-Learner:**

- Thing 53.94%
- [NCIT:C6833](http://purl.obolibrary.org/obo/NCIT_C6833) (Double Minutes) 53.33%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) and (not ([NCIT:C36474](http://purl.obolibrary.org/obo/NCIT_C36474) (Ring Chromosome 1))) 53.33%
- [NCIT:C2950](http://purl.obolibrary.org/obo/NCIT_C2950) (Cytogenetic Abnormality) 46.21%
- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 44.01%
- [NCIT:C6825](http://purl.obolibrary.org/obo/NCIT_C6825) (Numerical Chromosomal Abnormality) 42.50%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) 38.69%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) and (not ([NCIT:C39058](http://purl.obolibrary.org/obo/NCIT_C39058) (EGF Signaling Pathway))) 38.69%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) and (not ([NCIT:C39056](http://purl.obolibrary.org/obo/NCIT_C39056) (Vesicle Transport Pathway))) 38.69%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) and (not ([NCIT:C39055](http://purl.obolibrary.org/obo/NCIT_C39055) (Phospholipid Signaling Pathway))) 38.69%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) and (not ([NCIT:C39054](http://purl.obolibrary.org/obo/NCIT_C39054) (Extracellular Matrix Binding Pathway))) 38.69%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) and (not ([NCIT:C39040](http://purl.obolibrary.org/obo/NCIT_C39040) (CTCF Pathway))) 38.69%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) and (not ([NCIT:C39021](http://purl.obolibrary.org/obo/NCIT_C39021) (Cell Migration Pathway))) 38.69%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 38.69%
- [NCIT:C3360](http://purl.obolibrary.org/obo/NCIT_C3360) (Supernumerary Circular Chromosome) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 38.69%


